Bracco's $230 Million Investment Marks Major Step in U.S. Manufacturing for Contrast Media
Bracco, an internationally recognized pioneer in diagnostic imaging, has declared its intention to invest a significant $230 million to launch its very first manufacturing plant for injectable contrast media in the United States. This extensive commitment to establishing a facility in Sanford, North Carolina, is not just a mere expansion; it represents a strategic advancement in Bracco's ongoing global manufacturing philosophy. The investment is poised to create approximately 200 new jobs in various sectors including manufacturing, engineering, and administrative functions.
This significant milestone underscores Bracco's dedication to meeting the rising demand for diagnostic imaging products in the US market, which stands as the company's largest consumer base. Fulvio Renoldi Bracco, the Vice Chairman and CEO, emphasized the long-held commitment of Bracco towards improving people’s lives, noting that having local production capabilities in North Carolina would foster closer relationships with American healthcare facilities and enhance supply chain resilience.
The new facility is set against the backdrop of Bracco’s nearly century-long history of innovative contributions to diagnostic medicine. With this establishment, Bracco not only aims to broaden its manufacturing capacity but also to create a robust and responsive supply network that can better serve the needs of healthcare professionals and patients alike. This aligns with their mission of supporting healthcare efficacy and access to essential medical imaging materials.
Following the expansion, Bracco intends to revitalize its manufacturing ecosystem in conjunction with its existing facilities in Europe, Asia, and Canada. This project will facilitate a more geographically diversified production network, thus enhancing the resilience and reliability of its supply chain. The focus on constructing a state-of-the-art sterile manufacturing facility will ensure adherence to stringent quality standards synonymous with Bracco’s operations.
A key factor in the selection of Sanford, North Carolina, as the location for this new site was its rich repository of skilled talent and an established life sciences ecosystem. The investment is anticipated to contribute further to the local economy, primarily through job creation, while also providing an impetus to the ongoing growth of the life sciences sector across the region.
Bracco Group, founded in 1927, operates globally in over 100 countries and boasts a workforce exceeding 4,000 employees, with total revenues approximating €2 billion annually. The company's commitment to innovation is evident through its heavy investment in research and development, with around 9% of their reference turnover allocated towards this crucial area. They are also leading the charge in the advancement of products utilized in diagnostic imaging, including various contrast agents, and have initiated developments in artificial intelligence-enhanced solutions for healthcare applications.
Looking ahead, Bracco is poised to merge its long-standing heritage of innovation with modern advancements in healthcare and manufacturing technologies, ensuring they are well-equipped to cater to tomorrow's diagnostic imaging challenges. The company’s sustained investment in manufacturing capabilities will undoubtedly aid healthcare professionals in their critical roles, promoting improved patient outcomes on a global scale.
This significant milestone underscores Bracco's dedication to meeting the rising demand for diagnostic imaging products in the US market, which stands as the company's largest consumer base. Fulvio Renoldi Bracco, the Vice Chairman and CEO, emphasized the long-held commitment of Bracco towards improving people’s lives, noting that having local production capabilities in North Carolina would foster closer relationships with American healthcare facilities and enhance supply chain resilience.
The new facility is set against the backdrop of Bracco’s nearly century-long history of innovative contributions to diagnostic medicine. With this establishment, Bracco not only aims to broaden its manufacturing capacity but also to create a robust and responsive supply network that can better serve the needs of healthcare professionals and patients alike. This aligns with their mission of supporting healthcare efficacy and access to essential medical imaging materials.
Following the expansion, Bracco intends to revitalize its manufacturing ecosystem in conjunction with its existing facilities in Europe, Asia, and Canada. This project will facilitate a more geographically diversified production network, thus enhancing the resilience and reliability of its supply chain. The focus on constructing a state-of-the-art sterile manufacturing facility will ensure adherence to stringent quality standards synonymous with Bracco’s operations.
A key factor in the selection of Sanford, North Carolina, as the location for this new site was its rich repository of skilled talent and an established life sciences ecosystem. The investment is anticipated to contribute further to the local economy, primarily through job creation, while also providing an impetus to the ongoing growth of the life sciences sector across the region.
Bracco Group, founded in 1927, operates globally in over 100 countries and boasts a workforce exceeding 4,000 employees, with total revenues approximating €2 billion annually. The company's commitment to innovation is evident through its heavy investment in research and development, with around 9% of their reference turnover allocated towards this crucial area. They are also leading the charge in the advancement of products utilized in diagnostic imaging, including various contrast agents, and have initiated developments in artificial intelligence-enhanced solutions for healthcare applications.
Looking ahead, Bracco is poised to merge its long-standing heritage of innovation with modern advancements in healthcare and manufacturing technologies, ensuring they are well-equipped to cater to tomorrow's diagnostic imaging challenges. The company’s sustained investment in manufacturing capabilities will undoubtedly aid healthcare professionals in their critical roles, promoting improved patient outcomes on a global scale.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.